A client is receiving mesalamine 800 mg by mouth three times a day. Which assessment should the nurse perform to assess the effectiveness of the medication?
A.
Pupillary response.
B.
Peripheral pulses.
C.
Bowel patterns.
D.
Oxygen saturation.
The correct answer and Explanation is :
The correct answer is C. Bowel patterns.
Explanation:
Mesalamine is an anti-inflammatory medication primarily used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. Its effectiveness is largely assessed by monitoring the patient’s bowel patterns, as the primary goal of mesalamine therapy is to reduce inflammation in the gastrointestinal tract and improve the patient’s overall gastrointestinal health.
When assessing the effectiveness of mesalamine, a nurse should focus on the following aspects of bowel patterns:
- Frequency of Bowel Movements: A decrease in the frequency of diarrhea or loose stools is a positive indicator that mesalamine is controlling inflammation and helping restore normal bowel function.
- Consistency of Stool: The nurse should observe changes in stool consistency. An improvement from watery or loose stools to more formed stools suggests that the medication is effective.
- Presence of Blood or Mucus: Monitoring for the presence of blood or mucus in stools is crucial. A reduction in these symptoms indicates that mesalamine is helping to manage the underlying condition.
- Abdominal Pain and Discomfort: Evaluating the patient’s reports of abdominal pain, cramping, or bloating can provide insight into the medication’s effectiveness. A reduction in these symptoms is often associated with successful treatment.
- Quality of Life: Finally, improvements in the patient’s overall quality of life, including their ability to engage in daily activities without the distress caused by gastrointestinal symptoms, can also serve as an indirect measure of mesalamine’s effectiveness.
In contrast, assessing pupillary response, peripheral pulses, or oxygen saturation is less relevant in this context, as these measures do not directly correlate with the gastrointestinal effects that mesalamine aims to address. Therefore, the nurse should prioritize monitoring bowel patterns to evaluate the therapeutic outcome of mesalamine therapy effectively.